Of their findings, the authors alleged a potential paradigm shift in cardiovascular risk management. Frequently Asked Questions Your Weight Loss Journey Starts Here Getting to a healthier you shouldn't feel overwhelming
Many patients wonder, is Retatrutide better than Tirzepatide
These can include: But what about mental health
How do I know if my hair loss is due to B12 deficiency
Using two incretin-based compounds simultaneously would create overlapping receptor activation at the GLP-1 and GIP sites, dramatically increasing side effect risk without proportional efficacy gains
The GLP-1 class now includes multiple options at Defiance Health: Semaglutide (generic compounded, Wegovy, Ozempic) the original weight loss GLP-1, delivering 15-17% body weight loss on average at maintenance doses Tirzepatide (generic compounded, Zepbound, Mounjaro) a dual GIP/GLP-1 agonist, typically delivering 20-22% body weight loss at the highest dose Foundayo (orforglipron) FDA-approved April 1, 2026 , the first non-peptide GLP-1 pill that can be taken any time of day, with or without food